Peroxisome proliferator-activated receptor γ coactivator 1 β (PGC-1 β) protein attenuates vascular lesion formation by inhibition of chromatin loading of minichromosome maintenance complex in smooth muscle cells

Journal of Biological Chemistry

Volumn 288, Issue 7, 2013, Pages 4625-4636

  Guo, Yanhong ^a   Fan, Yanbo ^a   Zhang, Jifeng ^a   Chang, Lin ^a   Lin, Jiandie D ^b   Chen, Y Eugene ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PROCESS; COACTIVATORS; COMPLEX LOADING; KEY REGULATORS; NEOINTIMA FORMATION; OVER-EXPRESSION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; SMOOTH MUSCLE CELLS; THERAPEUTIC TARGETS; VASCULAR LESIONS; VASCULAR SMOOTH MUSCLE CELLS;

CHROMOSOMES; CYTOLOGY; MAINTENANCE; MUSCLE;

LOADING;

CYCLIN D1; METFORMIN; MINICHROMOSOME MAINTENANCE PROTEIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR LESION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERIES; CARRIER PROTEINS; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; MCM1 PROTEIN; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RNA-BINDING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84874100600     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.407452     Document Type: Article

References (57)

1. Dzau, V. J., Braun-Dullaeus, R. C., and Sedding, D. G. (2002) Vascular proliferation and atherosclerosis. New perspectives and therapeutic strategies. Nat. Med. 8, 1249-1256
2. Gibbons, G. H., and Dzau, V. J. (1994) The emerging concept of vascular remodeling. N. Engl. J. Med. 330, 1431-1438
3. Blaschke, F., Leppanen, O., Takata, Y., Caglayan, E., Liu, J., Fishbein, M. C, Kappert, K., Nakayama, K. I., Collins, A. R., Fleck, E., Hsueh, W. A., Law, R. E., and Bruemmer, D. (2004) Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ. Res. 95, e110-123
4. Bonta, P. I., and Pols., T. W., van Tiel, C. M., Vos, M., Arkenbout, E. K., Rohlena, J., Koch, K. T., de Maat, M. P., Tanck, M. W., de Winter, R.J., Pannekoek, H., Biessen, E. A., Bot, I., and de Vries, C. J. (2010) Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation. Circulation 121, 2023-2032
5. Fu, M., Zhang, J., Zhu, X., Myles, D. E., and Willson., T. M., Liu, X., and Chen, Y. E. (2001) Peroxisome proliferator-activated receptor γ inhibits transforming growth factor β-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J. Biol. Chem. 276, 45888-45894
6. Gizard, F., Amant, C, Barbier, O., Bellosta, S., Robillard, R., Percevault, F., Sevestre, H., Krimpenfort, P., Corsini, A., Rochette, J., Glineur, C, Fruchart, J. C, Torpier, G., and Staels, B. (2005) PPAR α inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a. J. Clin. Invest. 115, 3228-3238
7. Nomiyama, T., Nakamachi, T., Gizard, F., Heywood, E. B., and Jones., K. L., Ohkura, N, Kawamori, R., and Conneely., O. M., and Bruemmer, D. (2006) The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J. Biol. Chem. 281, 33467-33476
8. Zhang, J., Fu, M., Zhu, X., Xiao, Y., Mou, Y., Zheng, H., Akinbami, M. A., Wang, Q., and Chen, Y. E. (2002) Peroxisome proliferator-activated receptor S is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells. J. Biol. Chem. 277, 11505-11512
9. Smith, C L., and O'Malley, B. W. (2004) Coregulator function. A key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25, 45-71
10. Yu, S., and Reddy, J. K. (2007) Transcription coactivators for peroxisome proliferator-activated receptors. Biochim. Biophys. Acta 1771, 936-951
11. Lee, J. W., Lee, Y. C, Na, S. Y., Jung, D. J., and Lee, S.K. (2001) Transcriptional coregulators of the nuclear receptor superfamily. Coactivators and corepressors. Cell Mol. Life Sci. 58, 289-297
12. Horwitz, K. B., Jackson, T.A., Bain, D.L., Richer, J. K., Takimoto, G.S., and Tung, L. (1996) Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10, 1167-1177
13. Yu, C, Markan, K., Temple, K. A., Deplewski, D., and Brady., M. J., and Cohen, R. N (2005) The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor γ transcriptional activity and repress 3T3-L1 adipogenesis. J. Biol. Chem. 280, 13600-13605
14. Guan, H. P., Ishizuka, T., Chui, P. C, Lehrke, M., and Lazar, M. A. (2005) Corepressors selectively control the transcriptional activity of PPAR7 in adipocytes. Genes Dev. 19, 453-461
15. Liu, C, and Lin, J. D. (2011) PGC-1 coactivators in the control of energy metabolism. Acta Biochim. Biophys. Sin. 43, 248-257
16. Rowe, G. C, Jiang, A., and Arany, Z. (2010) PGC-1 coactivators in cardiac development and disease. Circ. Res. 107, 825-838
17. Arany, Z. (2008) PGC-1 coactivators and skeletal muscle adaptations in health and disease. Curr. Opin. Genet. Dev. 18, 426-434
18. Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., and Spiegelman, B. M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839
19. Lin, J., Puigserver, P., Donovan, J., Tarr, P., and Spiegelman, B. M. (2002) Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 277, 1645-1648
20. Kressler, D., and Schreiber., S. N., Knutti, D., and Kralli, A. (2002) The PGC-1-related protein PERC is a selective coactivator of estrogen receptor α J. Biol. Chem. 277, 13918-13925
21. Andersson, U., and Scarpulla, R. C. (2001) Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol. Cell. Biol. 21, 3738-3749
22. Vega, R. B., and Huss., J. M., and Kelly, D. P. (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell Biol. 20, 1868-1876
23. Tcherepanova, I., Puigserver, P., Norris, J. D., and Spiegelman., B. M., and McDonnell, D. P. (2000) Modulation of estrogen receptor-α transcriptional activity by the coactivator PGC-1. J. Biol. Chem. 275, 16302-16308
24. Knutti, D., Kaul, A., and Kralli, A. (2000) A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol. Cell Biol. 20, 2411-2422
25. Delerive, P., Wu, Y., Burris, T. P., and Chin., W. W., and Suen, C. S. (2002) PGC-1 functions as a transcriptional coactivator for the retinoid X receptors. J. Biol. Chem. 277, 3913-3917
26. Oberkofler, H., Schraml, E., Krempler, F., and Patsch, W. (2003) Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor γ co-activator 1a. Biochem. J. 371, 89-96
27. Yoon, J. C, Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., Newgard, C. B., and Spiegelman, B. M. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131-138
28. Hentschke, M., Süsens, U., and Borgmeyer, U. (2002) PGC-1 and PERC, coactivators of the estrogen receptor-related receptor γ. Biochem. Biophys. Res. Commun. 299, 872-879
29. Wu, Y., Delerive, P., Chin, W. W., and Burris, T. P. (2002) Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1. J. Biol. Chem. 277, 8898-8905
30. Qu, A., Jiang, C, Xu, M., Zhang, Y., Zhu, Y., Xu, Q., Zhang, C, and Wang, X. (2009) PGC-1 α attenuates neointimal formation via inhibition of vascular smooth muscle cell migration in the injured rat carotid artery. Am. J. Physiol. Cell Physiol. 297, C645-653
31. Zhu, L., Sun, G., Zhang, H., Zhang, Y., Chen, X., Jiang, X., Jiang, X., Krauss, S., Zhang, J., Xiang, Y., and Zhang, C Y. (2009) PGC-1α is a key regulator of glucose-induced proliferation and migration in vascular smooth muscle cells. PLoS ONE 4, e4182
32. Bruemmer, D., Yin, F., Liu, J., Kiyono, T., Fleck, E., Van Herle, A. J., and Law, R. E. (2003) Expression of minichromosome maintenance proteins in vascular smooth muscle cells is ERK/MAPK dependent. Exp. Cell Res. 290, 28-37
33. Chen, K. H., Guo, X., Ma, D., Guo, Y., Li, Q., Yang, D., Li, P., Qiu, X., Wen, S., Xiao, R. P., and Tang, J. (2004) Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol. 6, 872-883
34. Lin, J., and Tarr., P. T., Yang, R., Rhee, J., Puigserver, P., and Newgard., C. B., and Spiegelman, B. M. (2003) PGC-1/3 in the regulation of hepatic glucose and energy metabolism. J. Biol. Chem. 278, 30843-30848
35. Hernandez, C, Molusky, M., Li, Y., Li, S., and Lin, J. D. (2010) Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid. CellMetab. 12, 411-419
36. Uldry, M., Yang, W., St-Pierre, J., Lin, J., Seale, P., and Spiegelman, B. M. (2006) Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab. 3, 333-341
37. Méndez, J., and Stillman, B. (2000) Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle. Assembly of prereplication complexes in late mitosis. Mol. Cell Biol. 20, 8602-8612
38. Fan, Y., Guo, Y., Hamblin, M., Chang, L., Zhang, J., and Chen, Y. E. (2011) Inhibition of gluconeogenic genes by calcium-regulated heat-stable protein 1 via repression of peroxisome proliferator-activated receptor α J. Biol. Chem. 286, 40584-40594
39. Giaginis, C, Vgenopoulou, S., Vielh, P., and Theocharis, S. (2010) MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol. Histopathol. 25, 351-370
40. Lei, M. (2005) The MCM complex. Its role in DNA replication and implications for cancer therapy. Curr. Cancer Drug Targets 5, 365-380
41. Barnes, D. M., and Gillett, C. E. (1998) Cyclin D1 in breast cancer. Breast Cancer Res. Treat. 52, 1-15
42. Boyle, J. G., and Salt., I. P., and McKay, G. A. (2010) Metformin action on AMP-activated protein kinase. A translational research approach to understanding a potential new therapeutic target. Diabet. Med. 27, 1097-1106
43. Ben Sahra, I., Le Marchand-Brustel, Y., Tanti, J. F., and Bost, F. (2010) Metformin in cancer therapy. A new perspective for an old antidiabetic drug? Mol. Cancer Ther. 9, 1092-1099
44. Bost, F., and Sahra., I. B., Le Marchand-Brustel, Y., and Tanti, J. F. (2012) Metformin and cancer therapy. Curr. Opin. Oncol. 24, 103-108
45. Gallagher, E. J., and LeRoith, D. (2011) Diabetes, cancer, and metformin. Connections of metabolism and cell proliferation. Ann. N.Y. Acad. Sci. 1243, 54-68
46. Mamputu, J. C., and Wiernsperger., N. F., and Renier, G. (2003) Antiatherogenic properties of metformin. The experimental evidence. Diabetes Metab. 29, 6S71-76
47. Sharma, R. V., and Bhalla, R. C. (1995) Metformin attenuates agonist-stimulated calcium transients in vascular smooth muscle cells. Clin. Exp. Hypertens. 17, 913-929
48. Bell, S. P., and Dutta, A. (2002) DNA replication in eukaryotic cells. Annu. Rev. Biochem. 71, 333-374
49. Kelly, T. J., and Brown, G. W. (2000) Regulation of chromosome replication. Annu. Rev. Biochem. 69, 829-880
50. Nishitani, H., and Lygerou, Z. (2004) DNA replication licensing. Front. Biosci. 9, 2115-2132
51. Kearsey, S. E., and Labib, K. (1998) MCM proteins. Evolution, properties, and role in DNA replication. Biochim. Biophys. Acta 1398, 113-136
52. Maiorano, D., Lutzmann, M., and Méchali, M. (2006) MCM proteins and DNA replication. Curr. Opin. Cell Biol. 18, 130-136
53. Kikuchi, J., Kinoshita, I., Shimizu, Y., Kikuchi, E., Takeda, K., Aburatani, H., Oizumi, S., Konishi, J., Kaga, K., Matsuno, Y., Birrer, M. J., Nishimura, M., and Dosaka-Akita, H. (2011) Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer. Lung Cancer 72, 229-237
54. Liu, B., Fan, Z., Edgerton, S. M., Yang, X., and Lind., S. E., and Thor, A. D. (2011) Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions. Cell Cycle 10, 2959-2966
55. Kim, H.J., Park, K. G., and Yoo., E. K., Kim, Y. H., Kim, Y. N., and Kim., H. S., Kim, H. T., Park, J. Y., and Lee., K. U., Jang, W. G., Kim, J. G., Kim, B. W., and Lee, I. K. (2007) Effects of PGC-1α on TNF-α-induced MCP-1 and VCAM-1 expression and NF-ΚB activation in human aortic smooth muscle and endothelial cells. Antioxid. Redox Signal. 9, 301-307
56. Xiong, S., Salazar, G., San Martin, A., Ahmad, M., Patrushev, N., Hilenski, L., Nazarewicz, R. R., Ma, M., Ushio-Fukai, M., and Alexander, R. W. (2010) PGC-1 α serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy. J. Biol. Chem. 285, 2474-2487
57. Bailey, C. J. (2008) Metformin. Effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc. Drugs Ther. 22, 215-224